Suppr超能文献

钇[90Y]树脂微球选择性内放射治疗联合解剖性肝切除术治疗晚期肝细胞癌:一种潜在的治愈策略。

Selective internal radiation therapy with yttrium-90 resin microspheres followed by anatomical hepatectomy: A potential curative strategy in advanced hepatocellular carcinoma.

机构信息

Hepatopancreatobiliary Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China.

Hainan Cancer Hospital, Haikou, China.

出版信息

Asia Pac J Clin Oncol. 2024 Apr;20(2):319-322. doi: 10.1111/ajco.13900. Epub 2023 Jan 19.

Abstract

About 80% of hepatocellular carcinoma (HCC) patients are in advanced stages and ineligible for curative surgery. Palliative treatments just maintained limited survival, thus an effective downstaging therapy is badly needed. Here we report an initially unresectable patient who underwent radical hepatectomy after successful downstaging with selective internal radiation therapy (SIRT). A 34-year-old man was diagnosed with China Liver Cancer Staging (CNLC) IIIa HCC. Due to insufficient future liver remnant and vascular involvement, the patient was suggested to be unresectable. SIRT with yttrium-90 resin microspheres was given. At three months post-SIRT, a complete response was achieved. The tumor was downstaged to CNLC Ia stage. The patient underwent anatomical hepatectomy 5 months after SIRT. Histopathological examination of the resected specimen showed 4% viable tumor cells inside a necrotic mass. To our knowledge, this is the first case who underwent SIRT with yttrium-90 resin microspheres in China mainland. The success of the downstaging in this case renders a possible cure to be achieved in an initially unresectable patient. In addition, the nearly complete tumor necrosis in the resected specimen indicates a good prognosis post-surgery. This is the first case who underwent SIRT with yttrium-90 resin microspheres in China mainland. SIRT followed by anatomical hepatectomy is a potentially curative strategy for unresectable HCC, which deserves a confirmative trial in the future.

摘要

大约 80%的肝细胞癌 (HCC) 患者处于晚期,不符合根治性手术条件。姑息性治疗只能延长有限的生存时间,因此迫切需要有效的降期治疗。在这里,我们报告了一例最初无法切除的患者,在接受选择性内部放射治疗 (SIRT) 成功降期后接受了根治性肝切除术。一名 34 岁男性被诊断为中国肝癌分期 (CNLC) IIIa HCC。由于未来肝残余量不足和血管受累,建议该患者不可切除。给予钇-90 树脂微球 SIRT。SIRT 后三个月,达到完全缓解。肿瘤降期至 CNLC Ia 期。SIRT 后 5 个月,患者接受解剖性肝切除术。切除标本的组织病理学检查显示 4%的活肿瘤细胞位于坏死肿块内。据我们所知,这是中国大陆首例接受钇-90 树脂微球 SIRT 的病例。该病例的降期成功使最初不可切除的患者有可能获得治愈。此外,切除标本中几乎完全的肿瘤坏死表明术后预后良好。这是中国大陆首例接受钇-90 树脂微球 SIRT 的病例。SIRT 后行解剖性肝切除术是不可切除 HCC 的一种潜在治愈策略,值得未来进行确证性试验。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验